Clinical Trial Update: Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of BMS-823778 for uncontrolled hypertension in overweight/obese patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BMS-823778

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hypertension | Phase 2 | Status: TERMINATED